Econsent Healthcare Market Report: Market Size & Forecast 2026

The eConsent market encompasses software solutions that digitize the informed consent process in healthcare and clinical research settings. These platforms enable consent documents to be presented, reviewed, signed, and stored electronically, supporting multimedia elements such as videos and interactive questionnaires to improve patient comprehension.

• •No government statistical agency publishes dedicated market size figures for eConsent; estimates come from independent commercial research firms
• •Market size in 2025 is broadly estimated between $600-$680 million across multiple reports, with the user reference figure at $646 million

The primary catalyst for market expansion is the accelerating shift toward decentralized clinical trials (DCTs), which reduce or eliminate the need for in-person site visits and thereby require remote digital consent workflows. Regulatory frameworks such as the FDA's 21 CFR Part 11 establish standards for electronic records and signatures, creating a compliance imperative for sponsors and contract research organizations.

• •DCT adoption, accelerated by lessons from the COVID-19 pandemic, has made remote consent collection a standard requirement for many trials
• •Data privacy and security regulations including GDPR, HIPAA, and 21 CFR Part 11 mandate auditable electronic consent records
• •Patient-centricity trends in clinical development favor more engaging, multimedia-rich consent experiences

The market is typically segmented by component, software platforms, services, and system integration, and by end user, which includes pharmaceutical and biotechnology companies, contract research organizations (CROs), and healthcare institutions. North America currently dominates the market due to its concentration of clinical trial activity and stringent regulatory environment.

• •North America holds the largest regional share, driven by high clinical trial volume and advanced regulatory infrastructure
• •Europe represents a significant and growing segment, particularly with the implementation of GDPR consent requirements
• •Asia-Pacific is an emerging region with expanding clinical research activity and growing adoption of digital health solutions

What are the recent trends and outlook?

The market is expected to sustain double-digit growth through 2030, with near-term expansion driven by continued DCT adoption and the transition toward hybrid clinical trial models. Integration with broader clinical trial management ecosystems and the incorporation of advanced analytics and patient engagement features are emerging as key strategic priorities for vendors.

• •Hybrid and decentralized trial models are expected to become the norm rather than the exception for many sponsors post-pandemic
• •Advanced features such as real-time consent analytics, multilingual support, and integration with wearable data streams are anticipated to differentiate platforms in the coming years